John Löfblom
Impact in
-
- Monoclonal and Polyclonal Antibodies Research
- Radiopharmaceutical Chemistry and Applications
- Oncology top 5%
- HER2/EGFR in Cancer Research
- Peptidase Inhibition and Analysis
Papers in
-
- Monoclonal and Polyclonal Antibodies Research 93
- Radiopharmaceutical Chemistry and Applications 21
-
- Glycosylation and Glycoproteins Research 46
- Protein purification and stability 12
- Co-authors
- Stefan Ståhl (69 shared papers)Fredrik Y. Frejd (21 shared papers)Vladimir Tolmachev (34 shared papers)Shalom Stahl (4 shared papers)J. Carlsson (1 shared paper)Joachim Feldwisch (1 shared paper)Anna Orlova (37 shared papers)Mathias Uhlén (12 shared papers)
- Journals
- Scientific Reports (13 papers)Biotechnology Journal (9 papers)PLoS ONE (6 papers)International Journal of Molecular Sciences (5 papers)Cold Spring Harbor Protocols (5 papers)
- Partner nations
- SwedenRussiaUnited States
In The Last Decade
John Löfblom
107 papers receiving 3.2k citations
John Löfblom's Hit Papers
Peers
Comparison fields: 5 of 98
- Radiology, Nuclear Medicine and Imaging 2.2k
- Oncology 839
- Molecular Biology 1.9k
- Biotechnology 244
- Immunology 258
Countries citing papers authored by John Löfblom
This map shows the geographic impact of John Löfblom's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Löfblom with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Löfblom more than expected).
Fields of papers citing papers by John Löfblom
This network shows the impact of papers produced by John Löfblom. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Löfblom. The network helps show where John Löfblom may publish in the future.
Co-authors
The 25 scholars most cited alongside John Löfblom, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 113 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Affibody molecules: Engineered proteins for therapeutic, diagnostic and biotechnological applications Hit paper breakdown → | 2010 | 534 |
| 2 | 2017 | 304 | |
| 3 | 2006 | 138 | |
| 4 | 2012 | 128 | |
| 5 | 2011 | 123 | |
| 6 | 2011 | 93 | |
| 7 | 2008 | 90 | |
| 8 | 2010 | 73 | |
| 9 | 2008 | 65 | |
| 10 | 2013 | 60 | |
| 11 | 2015 | 59 | |
| 12 | 2012 | 55 | |
| 13 | 2016 | 51 | |
| 14 | 2014 | 51 | |
| 15 | 2014 | 49 | |
| 16 | 2017 | 45 | |
| 17 | 2014 | 43 | |
| 18 | 2014 | 42 | |
| 19 | 2019 | 41 | |
| 20 | 2012 | 40 |
About John Löfblom
John Löfblom is a scholar working on Radiology, Nuclear Medicine and Imaging, Molecular Biology, Oncology, Ecology and Biotechnology, having authored 113 papers that have together received 3.3k indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (93 papers), Glycosylation and Glycoproteins Research (46 papers), HER2/EGFR in Cancer Research (22 papers), Radiopharmaceutical Chemistry and Applications (21 papers), Bacteriophages and microbial interactions (13 papers), Protein purification and stability (12 papers), Alzheimer's disease research and treatments (8 papers) and Transgenic Plants and Applications (8 papers). The work is most often cited by research in Radiology, Nuclear Medicine and Imaging (2.2k citations), Oncology (839 citations), Molecular Biology (1.9k citations), Biotechnology (244 citations) and Immunology (258 citations). John Löfblom has collaborated with scholars based in Sweden, Russia and United States. Frequent co-authors include Stefan Ståhl, Fredrik Y. Frejd, Vladimir Tolmachev, Shalom Stahl, J. Carlsson, Joachim Feldwisch, Anna Orlova, Mathias Uhlén, Nina Kronqvist and Torbjörn Gräslund. Their work appears in journals such as Scientific Reports, Biotechnology Journal, PLoS ONE, International Journal of Molecular Sciences and Cold Spring Harbor Protocols.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.